Wire · regulatory
Maine waited years for a Lyme vaccine. RFK hobbled the panel needed for a smooth rollout
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 29 August 2026 · Fusion42 review
The Lyme vaccine developed by Pfizer and Valneva awaits FDA approval but faces an uncertain rollout due to the incapacitation of the CDC’s Advisory Committee on Immunization Practices after Robert F. Kennedy Jr. dismissed its members and replacements triggered a legal challenge, halting the committee's vaccine recommendations.
This Wire brief sits within Fusion42's coverage of Health.
◆ ◆ The Wire takeaway
Your vaccine startup in infectious disease faces a regulatory bottleneck where CDC recommendations stall your market access in the US. This legal and political blockage demands you diversify markets rapidly or push for alternative pathways to adoption.
◆ Coverage
1 source · 28 Aug 2026
◆ Related on Wire
◆ Topics